Home » Analyst Articles – US

Image for SOLV Energy (NASDAQ:MWH) Now Covered by Analysts at Jefferies Financial Group

SOLV Energy (NASDAQ:MWH) Now Covered by Analysts at Jefferies Financial Group

Jefferies Financial Group began coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research report released on Monday, MarketBeat reports. The brokerage issued a buy rating and a $32.00 price target on the stock. MWH... More of this article »
Image for AGI (NYSE:AGBK) Now Covered by Analysts at Citigroup

AGI (NYSE:AGBK) Now Covered by Analysts at Citigroup

Citigroup assumed coverage on shares of AGI (NYSE:AGBK – Free Report) in a research report report published on Monday morning, Marketbeat reports. The firm issued a buy rating and a $18.00 price objective on the stock. A number... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at Roth Mkm

SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at Roth Mkm

Roth Mkm started coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research report released on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $35.00 price target on the stock. Separately,... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at KeyCorp

SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at KeyCorp

KeyCorp initiated coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research report sent to investors on Monday morning, Marketbeat.com reports. The brokerage issued an overweight rating and a $34.00 target price... More of this article »
Image for AGI (NYSE:AGBK) Now Covered by Morgan Stanley

AGI (NYSE:AGBK) Now Covered by Morgan Stanley

Morgan Stanley assumed coverage on shares of AGI (NYSE:AGBK – Free Report) in a research report released on Monday, MarketBeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. AGBK has... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Now Covered by UBS Group

SOLV Energy (NASDAQ:MWH) Now Covered by UBS Group

UBS Group assumed coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a report issued on Monday, Marketbeat.com reports. The firm issued a buy rating and a $42.00 target price on the stock. A number of other equities... More of this article »
Image for Alta Equipment Group (NYSE:ALTG) Upgraded to Outperform at Raymond James Financial

Alta Equipment Group (NYSE:ALTG) Upgraded to Outperform at Raymond James Financial

Raymond James Financial upgraded shares of Alta Equipment Group (NYSE:ALTG – Free Report) from a market perform rating to an outperform rating in a research report released on Monday morning, Marketbeat reports. They currently... More of this article »
Image for Orthofix Medical (NASDAQ:OFIX) Price Target Cut to $18.00 by Analysts at Stifel Nicolaus

Orthofix Medical (NASDAQ:OFIX) Price Target Cut to $18.00 by Analysts at Stifel Nicolaus

Orthofix Medical (NASDAQ:OFIX – Free Report) had its target price reduced by Stifel Nicolaus from $22.00 to $18.00 in a research report report published on Monday,Benzinga reports. Stifel Nicolaus currently has a buy rating on... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Now Covered by Wolfe Research

SOLV Energy (NASDAQ:MWH) Now Covered by Wolfe Research

Wolfe Research began coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The firm issued an outperform rating and a $35.00 price target on the stock. A... More of this article »
Image for AGI (NYSE:AGBK) Now Covered by Analysts at Susquehanna

AGI (NYSE:AGBK) Now Covered by Analysts at Susquehanna

Susquehanna assumed coverage on shares of AGI (NYSE:AGBK – Free Report) in a report released on Monday, MarketBeat Ratings reports. The brokerage issued a positive rating and a $17.00 price target on the stock. AGBK has been... More of this article »
Image for Olema Pharmaceuticals (NASDAQ:OLMA) Given New $38.00 Price Target at HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA) Given New $38.00 Price Target at HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price target cut by HC Wainwright from $45.00 to $38.00 in a research report report published on Monday, Marketbeat reports. They currently have a buy rating on the stock. Several... More of this article »
Image for AGI (NYSE:AGBK) Now Covered by Analysts at Oppenheimer

AGI (NYSE:AGBK) Now Covered by Analysts at Oppenheimer

Oppenheimer initiated coverage on shares of AGI (NYSE:AGBK – Free Report) in a research report sent to investors on Monday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $15.00 target price... More of this article »
Image for Paramount Skydance (NASDAQ:PSKY) Coverage Initiated by Analysts at Wells Fargo & Company

Paramount Skydance (NASDAQ:PSKY) Coverage Initiated by Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Paramount Skydance (NASDAQ:PSKY – Free Report) in a research note released on Monday. The brokerage issued an underweight rating and a $10.00 price objective on the stock. A... More of this article »
Image for Citigroup Issues Positive Forecast for Micron Technology (NASDAQ:MU) Stock Price

Citigroup Issues Positive Forecast for Micron Technology (NASDAQ:MU) Stock Price

Micron Technology (NASDAQ:MU – Free Report) had its target price hoisted by Citigroup from $385.00 to $430.00 in a research note published on Monday morning,Benzinga reports. The firm currently has a buy rating on the semiconductor... More of this article »
Image for Lyell Immunopharma (NASDAQ:LYEL) Coverage Initiated by Analysts at Citizens Jmp

Lyell Immunopharma (NASDAQ:LYEL) Coverage Initiated by Analysts at Citizens Jmp

Citizens Jmp assumed coverage on shares of Lyell Immunopharma (NASDAQ:LYEL – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The brokerage issued a market outperform rating and a $34.00... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Now Covered by Robert W. Baird

SOLV Energy (NASDAQ:MWH) Now Covered by Robert W. Baird

Robert W. Baird initiated coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The firm issued an outperform rating and a $36.00 price target on the... More of this article »
Image for Netflix (NASDAQ:NFLX) Coverage Initiated by Analysts at Wells Fargo & Company

Netflix (NASDAQ:NFLX) Coverage Initiated by Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Netflix (NASDAQ:NFLX – Free Report) in a report published on Monday, MarketBeat.com reports. The brokerage issued an equal weight rating and a $105.00 price objective... More of this article »
Image for MercadoLibre (NASDAQ:MELI) Given New $2,600.00 Price Target at Morgan Stanley

MercadoLibre (NASDAQ:MELI) Given New $2,600.00 Price Target at Morgan Stanley

MercadoLibre (NASDAQ:MELI – Free Report) had its price objective trimmed by Morgan Stanley from $2,800.00 to $2,600.00 in a report released on Monday morning, MarketBeat.com reports. The brokerage currently has an overweight... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at Guggenheim

SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at Guggenheim

Guggenheim started coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a report released on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $37.00 target price on the stock. A number of... More of this article »
Image for SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at TD Cowen

SOLV Energy (NASDAQ:MWH) Coverage Initiated by Analysts at TD Cowen

TD Cowen assumed coverage on shares of SOLV Energy (NASDAQ:MWH – Free Report) in a research report sent to investors on Monday morning, MarketBeat.com reports. The firm issued a buy rating and a $32.00 price target on the stock. Other... More of this article »
Image for Fortrea (NASDAQ:FTRE) Rating Increased to Buy at TD Cowen

Fortrea (NASDAQ:FTRE) Rating Increased to Buy at TD Cowen

TD Cowen upgraded shares of Fortrea (NASDAQ:FTRE – Free Report) from a hold rating to a buy rating in a report released on Monday morning, Marketbeat.com reports. TD Cowen currently has $15.00 target price on the stock. Several... More of this article »
Image for H2O America (NASDAQ:HTO) Given New $63.00 Price Target at Barclays

H2O America (NASDAQ:HTO) Given New $63.00 Price Target at Barclays

H2O America (NASDAQ:HTO – Free Report) had its target price boosted by Barclays from $61.00 to $63.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the utilities... More of this article »
Image for Webull (NASDAQ:BULL) Now Covered by Compass Point

Webull (NASDAQ:BULL) Now Covered by Compass Point

Compass Point began coverage on shares of Webull (NASDAQ:BULL – Free Report) in a report published on Monday morning, MarketBeat.com reports. The firm issued a buy rating and a $9.00 price objective on the stock. Several other... More of this article »
Image for argenex’s (ARGX) Outperform Rating Reaffirmed at Wedbush

argenex’s (ARGX) Outperform Rating Reaffirmed at Wedbush

Wedbush reissued their outperform rating on shares of argenex (NASDAQ:ARGX – Free Report) in a research note issued to investors on Monday,Benzinga reports. They currently have a $1,000.00 price target on the stock. ARGX has... More of this article »
Image for Day One Biopharmaceuticals’ (DAWN) Neutral Rating Reaffirmed at Wedbush

Day One Biopharmaceuticals’ (DAWN) Neutral Rating Reaffirmed at Wedbush

Wedbush reaffirmed their neutral rating on shares of Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. Wedbush currently has a $21.50 target price... More of this article »
Image for Citigroup Issues Positive Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Citigroup Issues Positive Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Eyepoint Pharmaceuticals (NASDAQ:EYPT – Free Report) had its price objective lifted by Citigroup from $31.00 to $35.00 in a research report report published on Monday morning,Benzinga reports. Citigroup currently has a buy rating... More of this article »
Image for Nomura Issues Positive Forecast for JD.com (NASDAQ:JD) Stock Price

Nomura Issues Positive Forecast for JD.com (NASDAQ:JD) Stock Price

JD.com (NASDAQ:JD – Free Report) had its target price raised by Nomura from $37.00 to $40.00 in a research note issued to investors on Monday morning,MarketScreener reports. They currently have a buy rating on the information... More of this article »
Image for Werner Enterprises (NASDAQ:WERN) Upgraded to Neutral at Citigroup

Werner Enterprises (NASDAQ:WERN) Upgraded to Neutral at Citigroup

Citigroup upgraded shares of Werner Enterprises (NASDAQ:WERN – Free Report) from a sell rating to a neutral rating in a research note released on Monday morning, Marketbeat.com reports. Citigroup currently has $34.00 price target... More of this article »
Image for CytomX Therapeutics’ (CTMX) “Buy” Rating Reaffirmed at Guggenheim

CytomX Therapeutics’ (CTMX) “Buy” Rating Reaffirmed at Guggenheim

Guggenheim restated their buy rating on shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) in a research report released on Monday morning,Benzinga reports. Guggenheim currently has a $10.00 target price on the biotechnology... More of this article »
Image for Incyte (NASDAQ:INCY) Given “Buy” Rating at HC Wainwright

Incyte (NASDAQ:INCY) Given “Buy” Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note released on Monday,Benzinga reports. The brokerage currently has a $135.00 price target on the biopharmaceutical company’s... More of this article »
Image for American Electric Power (NASDAQ:AEP) Price Target Raised to $135.00 at UBS Group

American Electric Power (NASDAQ:AEP) Price Target Raised to $135.00 at UBS Group

American Electric Power (NASDAQ:AEP – Free Report) had its price target lifted by UBS Group from $132.00 to $135.00 in a report published on Monday,MarketScreener reports. A number of other analysts also recently issued reports... More of this article »
Image for Audioeye (NASDAQ:AEYE) Price Target Lowered to $12.00 at HC Wainwright

Audioeye (NASDAQ:AEYE) Price Target Lowered to $12.00 at HC Wainwright

Audioeye (NASDAQ:AEYE – Free Report) had its target price decreased by HC Wainwright from $18.00 to $12.00 in a report issued on Monday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several... More of this article »
Image for APA (NASDAQ:APA) Given New $45.00 Price Target at Wolfe Research

APA (NASDAQ:APA) Given New $45.00 Price Target at Wolfe Research

APA (NASDAQ:APA – Free Report) had its price objective hoisted by Wolfe Research from $39.00 to $45.00 in a research report released on Monday,MarketScreener reports. Several other research analysts also recently weighed in on... More of this article »
Image for H World Group (NASDAQ:HTHT) Upgraded by UBS Group to Buy Rating

H World Group (NASDAQ:HTHT) Upgraded by UBS Group to Buy Rating

UBS Group upgraded shares of H World Group (NASDAQ:HTHT – Free Report) from a neutral rating to a buy rating in a research note published on Monday, MarketBeat.com reports. They currently have $62.40 price objective on the stock. A... More of this article »
Image for Immuneering (NASDAQ:IMRX) Receives Buy Rating from Needham & Company LLC

Immuneering (NASDAQ:IMRX) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a report published on Monday,Benzinga reports. They currently have a $11.00 target price on the stock. IMRX has been... More of this article »
Image for 5E Advanced Materials (NASDAQ:FEAM) Price Target Cut to $5.75 by Analysts at HC Wainwright

5E Advanced Materials (NASDAQ:FEAM) Price Target Cut to $5.75 by Analysts at HC Wainwright

5E Advanced Materials (NASDAQ:FEAM – Free Report) had its price target decreased by HC Wainwright from $9.25 to $5.75 in a report issued on Monday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several... More of this article »
Image for DexCom (NASDAQ:DXCM) Given “Buy” Rating at BTIG Research

DexCom (NASDAQ:DXCM) Given “Buy” Rating at BTIG Research

BTIG Research reiterated their buy rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research note issued to investors on Monday,Benzinga reports. They currently have a $85.00 target price on the medical device company’s... More of this article »
Image for APA (NASDAQ:APA) Given New $26.00 Price Target at Jefferies Financial Group

APA (NASDAQ:APA) Given New $26.00 Price Target at Jefferies Financial Group

APA (NASDAQ:APA – Free Report) had its price target upped by Jefferies Financial Group from $22.00 to $26.00 in a report published on Monday,MarketScreener reports. A number of other brokerages have also issued reports on APA.... More of this article »
Image for Coinbase Global (NASDAQ:COIN) Price Target Cut to $277.00 by Analysts at Rothschild & Co Redburn

Coinbase Global (NASDAQ:COIN) Price Target Cut to $277.00 by Analysts at Rothschild & Co Redburn

Coinbase Global (NASDAQ:COIN) had its target price cut by Rothschild & Co Redburn from $288.00 to $277.00 in a research report released on Monday morning,MarketScreener reports. COIN has been the subject of several other research... More of this article »
Image for Grid Dynamics (NASDAQ:GDYN) Price Target Lowered to $12.00 at Northland Securities

Grid Dynamics (NASDAQ:GDYN) Price Target Lowered to $12.00 at Northland Securities

Grid Dynamics (NASDAQ:GDYN – Free Report) had its price target decreased by Northland Securities from $14.00 to $12.00 in a report released on Monday,Benzinga reports. Northland Securities currently has an outperform rating on... More of this article »
Image for Doximity (NASDAQ:DOCS) Receives “Outperform” Rating from Royal Bank Of Canada

Doximity (NASDAQ:DOCS) Receives “Outperform” Rating from Royal Bank Of Canada

Royal Bank Of Canada reissued their outperform rating on shares of Doximity (NASDAQ:DOCS – Free Report) in a report released on Monday,Benzinga reports. Royal Bank Of Canada currently has a $44.00 price target on the stock. Several... More of this article »
Image for enGene’s (ENGN) Buy Rating Reaffirmed at HC Wainwright

enGene’s (ENGN) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of enGene (NASDAQ:ENGN – Free Report) in a report released on Monday morning,Benzinga reports. The brokerage currently has a $25.00 price target on the stock. ENGN has been the... More of this article »
Image for Jade Biosciences’ (JBIO) Outperform Rating Reaffirmed at Wedbush

Jade Biosciences’ (JBIO) Outperform Rating Reaffirmed at Wedbush

Wedbush reaffirmed their outperform rating on shares of Jade Biosciences (NASDAQ:JBIO – Free Report) in a research note released on Monday,Benzinga reports. Wedbush currently has a $24.00 price objective on the stock. A number... More of this article »
Image for Bridger Aerospace Group (NASDAQ:BAER) Price Target Lowered to $5.00 at Canaccord Genuity Group

Bridger Aerospace Group (NASDAQ:BAER) Price Target Lowered to $5.00 at Canaccord Genuity Group

Bridger Aerospace Group (NASDAQ:BAER – Free Report) had its price target decreased by Canaccord Genuity Group from $5.25 to $5.00 in a research report released on Monday,Benzinga reports. Canaccord Genuity Group currently has... More of this article »
Image for EQPT (NASDAQ:EQPT) Given New $31.00 Price Target at Citigroup

EQPT (NASDAQ:EQPT) Given New $31.00 Price Target at Citigroup

EQPT (NASDAQ:EQPT – Free Report) had its price objective lowered by Citigroup from $35.00 to $31.00 in a research report released on Monday,Benzinga reports. Citigroup currently has a neutral rating on the stock. Other analysts... More of this article »
Image for Immix Biopharma (NASDAQ:IMMX) Coverage Initiated by Analysts at Citizens Jmp

Immix Biopharma (NASDAQ:IMMX) Coverage Initiated by Analysts at Citizens Jmp

Citizens Jmp started coverage on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a research note published on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $23.00 target price on... More of this article »
Image for Trevi Therapeutics (NASDAQ:TRVI) Receives “Buy” Rating from HC Wainwright

Trevi Therapeutics (NASDAQ:TRVI) Receives “Buy” Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a report released on Monday morning,Benzinga reports. HC Wainwright currently has a $21.00 price objective on the stock. TRVI... More of this article »
Image for ArcBest (NASDAQ:ARCB) Given New $107.00 Price Target at Citigroup

ArcBest (NASDAQ:ARCB) Given New $107.00 Price Target at Citigroup

ArcBest (NASDAQ:ARCB – Free Report) had its target price boosted by Citigroup from $105.00 to $107.00 in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has a buy rating on the transportation... More of this article »
Image for Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital

Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has a $19.00 price objective... More of this article »
Image for Icon (NASDAQ:ICLR) Price Target Lowered to $120.00 at Barclays

Icon (NASDAQ:ICLR) Price Target Lowered to $120.00 at Barclays

Icon (NASDAQ:ICLR – Free Report) had its target price cut by Barclays from $200.00 to $120.00 in a report issued on Monday,Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Other... More of this article »